Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Clinical Nuclear Medicine|October 14, 2022
A Viability Analysis of Tumor-Bearing Frozen Autograft for the Reconstruction After Resection of Malignant Bone Tumors Using 99m Tc-MDP ScintigraphyYoshihiro Araki, Norio Yamamoto, Katsuhiro Hayashi, et al.
In Vivo (Athens, Greece)|December 31, 2024
The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In VivoSei Morinaga, Ming Zhao, Kohei Mizuta, et al.
In Vivo (Athens, Greece)|February 26, 2025
HT1080 Fibrosarcoma With Acquired Trabectedin Resistance: Increased Malignancy But Sustained Sensitivity to Methionine RestrictionSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Spine Surgery and Related Research|February 12, 2024
Ten-Year Clinical Outcomes of Endoscope-Assisted Minimally Invasive Surgical Decompression for Lumbar Spinal Stenosis with Degenerative Spondylolisthesis and Comparison with Conservative TreatmentKoshi Nambu, Hitoaki Numata, Junya Yoshitani, et al.
Scientific Reports|January 22, 2021
The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcomaYoshihiro Araki, Norio Yamamoto, Katsuhiro Hayashi, et al.
Anticancer Research|March 4, 2025
Highly Synergistic Eradication of 143B Osteosarcoma Cells In Vitro by the Combination of Recombinant Methioninase, Chloroquine, and Rapamycin Targeting Methionine Addiction, Autophagy, and mTOR, RespectivelySei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Anticancer Research|December 31, 2024
Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer CellsSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)|April 28, 2025
HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude MiceSei Morinaga, Kohei Mizuta, Byung Mo Kang, et al.
Frontiers in Oncology|December 24, 2025
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expressionSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)|December 31, 2024
Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse ModelsSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Pageof 12